Anna Tostevin

736 total citations
18 papers, 258 citations indexed

About

Anna Tostevin is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Anna Tostevin has authored 18 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 16 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Anna Tostevin's work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (11 papers). Anna Tostevin is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (11 papers). Anna Tostevin collaborates with scholars based in United Kingdom, South Africa and Australia. Anna Tostevin's co-authors include David Dunn, Valérie Delpech, Anton Pozniak, Caroline Sabin, Deenan Pillay, Ellen White, Alison Brown, Duncan Churchill, Erasmus Smit and Stéphane Hué and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Anna Tostevin

18 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Tostevin United Kingdom 10 229 195 74 27 17 18 258
Yacine Saïdi France 9 207 0.9× 154 0.8× 44 0.6× 22 0.8× 52 3.1× 12 267
Claudia Palladino Spain 10 172 0.8× 119 0.6× 66 0.9× 14 0.5× 25 1.5× 27 233
Linda Harrison United States 7 253 1.1× 217 1.1× 57 0.8× 14 0.5× 30 1.8× 10 290
Daniela Tapia‐Trejo Mexico 10 205 0.9× 164 0.8× 62 0.8× 19 0.7× 7 0.4× 25 228
Hursch Patel United States 10 179 0.8× 113 0.6× 38 0.5× 7 0.3× 14 0.8× 24 240
Erin Rottinghaus United States 5 193 0.8× 163 0.8× 64 0.9× 24 0.9× 15 0.9× 8 237
Wan-Lin Yang Switzerland 7 206 0.9× 175 0.9× 79 1.1× 7 0.3× 13 0.8× 9 228
Kenny Chi-Wai Chan Hong Kong 9 184 0.8× 188 1.0× 76 1.0× 16 0.6× 18 1.1× 17 269
Carlo Sacdalan Thailand 12 242 1.1× 218 1.1× 104 1.4× 28 1.0× 73 4.3× 34 330
Junine Toy Canada 6 140 0.6× 95 0.5× 50 0.7× 27 1.0× 14 0.8× 20 164

Countries citing papers authored by Anna Tostevin

Since Specialization
Citations

This map shows the geographic impact of Anna Tostevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tostevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tostevin more than expected).

Fields of papers citing papers by Anna Tostevin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tostevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tostevin. The network helps show where Anna Tostevin may publish in the future.

Co-authorship network of co-authors of Anna Tostevin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tostevin. A scholar is included among the top collaborators of Anna Tostevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tostevin. Anna Tostevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Moore, Amelia E.B., James E. Burns, Ana Milinkovic, et al.. (2023). Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV. AIDS. 38(4). 521–529. 5 indexed citations
3.
Tostevin, Anna, et al.. (2021). Using machine learning and big data to explore the drug resistance landscape in HIV. PLoS Computational Biology. 17(8). e1008873–e1008873. 17 indexed citations
4.
5.
Stirrup, Oliver, David Asboe, Anton Pozniak, et al.. (2020). Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation. HIV Medicine. 21(5). 309–321. 4 indexed citations
6.
Vu, Stéphane Le, Oliver Ratmann, Valérie Delpech, et al.. (2019). HIV-1 Transmission Patterns in Men Who Have Sex with Men: Insights from Genetic Source Attribution Analysis. AIDS Research and Human Retroviruses. 35(9). 805–813. 8 indexed citations
7.
Dunn, David, Wolfgang Stöhr, Alejandro Arenas‐Pinto, et al.. (2018). Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy. Journal of Clinical Virology. 101. 63–65. 6 indexed citations
8.
Ragonnet‐Cronin, Manon, Stéphane Hué, Emma B. Hodcroft, et al.. (2018). Non-disclosed men who have sex with men in UK HIV transmission networks: phylogenetic analysis of surveillance data. The Lancet HIV. 5(6). e309–e316. 29 indexed citations
9.
Stirrup, Oliver, David Dunn, Anna Tostevin, et al.. (2018). Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data. AIDS Research and Therapy. 15(1). 11–11. 3 indexed citations
10.
Mbisa, Jean L., Peter Kirwan, Anna Tostevin, et al.. (2018). Determining the origins of HIV-1 drug-resistant minority variants in people who are recently infected using phylogenetic reconstruction. 3 indexed citations
11.
Volz, Erik, Stéphane Le Vu, Oliver Ratmann, et al.. (2018). Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control. The Journal of Infectious Diseases. 217(10). 1522–1529. 18 indexed citations
12.
Collins, Intira Jeannie, Caroline Foster, Anna Tostevin, et al.. (2017). Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland. Clinical Infectious Diseases. 64(8). 1105–1112. 28 indexed citations
13.
Vu, Stéphane Le, Oliver Ratmann, Valérie Delpech, et al.. (2017). Comparison of cluster-based and source-attribution methods for estimating transmission risk using large HIV sequence databases. Epidemics. 23. 1–10. 20 indexed citations
14.
Schultze, Anna, Roger Paredes, Caroline Sabin, et al.. (2017). The Association between Detected drug Resistance Mutations and CD4+ T-Cell Decline in HIV-Positive Individuals Maintained on a Failing Treatment Regimen. Antiviral Therapy. 23(2). 105–116. 4 indexed citations
15.
Smit, Erasmus, Ellen White, Duncan A. Clark, et al.. (2017). An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs. Journal of Antimicrobial Chemotherapy. 72(7). 2075–2082. 12 indexed citations
16.
White, Ellen, Erasmus Smit, Duncan Churchill, et al.. (2016). No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom. The Journal of Infectious Diseases. 214(9). 1302–1308. 9 indexed citations
17.
Bouzidi, Kate El, Ellen White, Jean L. Mbisa, et al.. (2016). HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK. Journal of Antimicrobial Chemotherapy. 71(12). 3487–3494. 21 indexed citations
18.
Tostevin, Anna, Ellen White, David Dunn, et al.. (2016). Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom. HIV Medicine. 18(3). 204–213. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yacine Saïdi Breakdown of academic impact, for papers by Claudia Palladino Breakdown of academic impact, for papers by Linda Harrison Breakdown of academic impact, for papers by Daniela Tapia‐Trejo Breakdown of academic impact, for papers by Hursch Patel Breakdown of academic impact, for papers by Erin Rottinghaus Breakdown of academic impact, for papers by Wan-Lin Yang Breakdown of academic impact, for papers by Kenny Chi-Wai Chan Breakdown of academic impact, for papers by Carlo Sacdalan Breakdown of academic impact, for papers by Junine Toy
Rankless by CCL
2026